KalVista Pharmaceuticals, Inc.
KALV
$27.00
$0.010.04%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 07/31/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -88.96M | -117.30M | -160.44M | -160.44M | -140.79M |
| Total Depreciation and Amortization | 1.19M | 1.09M | 732.00K | 732.00K | 704.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 45.22M | 34.96M | 22.65M | 22.65M | 14.92M |
| Change in Net Operating Assets | -21.86M | -16.27M | 2.30M | 2.30M | 4.69M |
| Cash from Operations | -64.40M | -97.52M | -134.75M | -174.39M | -160.11M |
| Capital Expenditure | -1.11M | -1.28M | -602.00K | -602.00K | -333.00K |
| Sale of Property, Plant, and Equipment | -12.00K | -12.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 29.63M | 26.98M | 26.66M | 26.66M | 42.29M |
| Cash from Investing | 28.51M | 25.70M | 26.06M | 74.73M | 90.63M |
| Total Debt Issued | 69.14M | 69.14M | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.75M | 3.51M | 60.06M | 60.06M | 61.77M |
| Repurchase of Common Stock | -810.00K | -810.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 33.17M | 33.17M | 117.15M | 117.15M | 95.23M |
| Cash from Financing | 104.25M | 105.00M | 177.21M | 177.50M | 157.29M |
| Foreign Exchange rate Adjustments | -5.75M | -1.83M | 3.71M | 3.71M | 1.11M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 62.61M | 31.36M | 72.23M | 81.96M | 89.33M |